Skip to main content
Signal8

GSK plc

SEC insider (Form 3/4/5 filer). CIK 0001131399. 10% Owner at Wave Life Sciences Ltd. (WVE). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 11, 2025. Located in LONDON, X0.

Companies GSK plc has filed insider reports for

  • Wave Life Sciences Ltd. (WVE): 10% Owner
GSK plc profile photo

GSK plc

CIK: 0001131399

Transaction Breakdown

Open Market Buys (P)2 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Wave Life Sciences Ltd. logo
WVE

Wave Life Sciences Ltd.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Dec 11, 2025
    Purchase
    Indirect
    1.5M shares at avg. $19.00$27.9M
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Sep 27, 2024
    Purchase
    Indirect
    2.8M shares at avg. $8.00$22.3M

1-2 of 2